Please login to the form below

Not currently logged in
Email:
Password:

PhRMA appoints senior government affairs position

Charles Clapton has senior experience on Capitol Hill
PhRMA charles clapton

US trade body the Pharmaceutical Research and Manufacturers of America (PhRMA) has appointed Charles 'Chuck' Clapton as senior VP, federal advocacy.

Taking on the role from March 17, Clapton will be responsible for leading PhRMA's federal government affairs initiatives and advancing its legislative agenda.

This includes working with stakeholders to develop health policies that cater for PhRMA's priorities of innovation and patient access to medicines.

Clapton said: “I look forward to representing PhRMA members and assisting their efforts to help patients improve access to new treatments and support policies foster the continuing development of new treatments and cures."

He has a legal background, serving most recently at law firm HoganLovells, where he was responsible for many healthcare clients and his past experience includes senior public sector roles on the House Energy & Commerce Committee, Ways & Means Committee, Office of the Speaker and the Senate Health, Education, Labor and Pensions Committee.

During this time, he worked on Medicare and issues related to the FDA.

Chip Davis, executive VP, advocacy and member relations at PhRMA, commented: "Chuck's experience, reputation, and results-oriented focus during his distinguished career on Capitol Hill will be tremendous assets to PhRMA and its members as he leads our Federal Advocacy efforts."

3rd March 2014

From: Marketing, Regulatory, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics